GregoryMGottschlichMD

Allergy & Immunology • Cincinnati, OH

Pediatric Asthma & Allergic Conditions

Physician

Join to view full profile

Dr. Gottschlich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gottschlich's full profile

Already have an account?

Office
4260 Glendale Milford Rd
Suite 201
Cincinnati, OH 45242
Phone+1 513-769-2762

Fax+1 513-769-2769

Education & Training

Wake Forest University Baptist Medical CenterFellowship, Allergy and Immunology, 1986 - 1988
Jewish Hospital of CincinnatiResidency, Internal Medicine, 1983 - 1985
Wright State UniversityInternship, Internal Medicine, 1982 - 1983
Ohio State University College of MedicineClass of 1982

Certifications & Licensure

OH State Medical License 1983 - 2027
SC State Medical License 2023 - 2025
KY State Medical License 1989 - 2006
NC State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2008 Dec 01
Completed
Phase 2
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease Start of enrollment: 2011 Nov 01
Completed
Phase 2
Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee Start of enrollment: 2014 Jun 01
Unknown status
Not Applicable
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma Start of enrollment: 2014 Sep 01
Completed
Phase 1
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

52 citations
Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: A double-blind study
Allen Litwin, Michael Flanagan, Gregory Entis, Gregory Gottschlich, Robert E. Esch
The Journal of Allergy and Clinical Immunology. 1997-07-01
67 citations
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
Anjuli Nayak, Charles H. Banov, Jonathan Corren, Barry K. Feinstein, Anthony A. Floreani
Annals of Allergy, Asthma & Immunology. 2000-04-01
18 citations
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocompon...
Donald P. Tashkin, Fernando J. Martinez, Roberto Rodriguez-Roisin, Charles Fogarty, Mark Gotfried
Respiratory Medicine. 2016-11-01

Professional Memberships

American Academy of Allergy Asthma and Immunology - AAAAI
Fellow